advertisement
Jiao J 22
Showing records 1 to 22 | Display all abstracts from Jiao J126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Kolko M
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Silverstein SM
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Tatham AJ
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Oddone F; Kolko M
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Lim KS; Wells AP
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Brinkmann CK
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Shiu M
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Christie WC; Bicket AK
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Uy HS; Sarkisian SR
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Gous PNJ
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Ho Q
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Luebke J; Maram J
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Jiao J; Kim K
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Nguyen A
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Goodkin ML
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Craven ER; Pu Y
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Bejanian M; Robinson MR
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Jiao J
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
Paauw JD
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Bejanian M
Drugs 2025; 85: 557-570
126652 Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty
American Journal of Ophthalmology 2025; 272: 19-37
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Robinson MR;
Drugs 2025; 85: 557-570
